Compare AIOT & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIOT | DRTS |
|---|---|---|
| Founded | 1993 | 2015 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 665.1M | 607.1M |
| IPO Year | N/A | N/A |
| Metric | AIOT | DRTS |
|---|---|---|
| Price | $5.30 | $7.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $10.50 | $8.00 |
| AVG Volume (30 Days) | ★ 892.7K | 449.2K |
| Earning Date | 02-09-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $425,867,000.00 | N/A |
| Revenue This Year | $23.71 | N/A |
| Revenue Next Year | $9.22 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 92.93 | N/A |
| 52 Week Low | $3.70 | $2.30 |
| 52 Week High | $8.71 | $7.89 |
| Indicator | AIOT | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 64.37 |
| Support Level | $5.17 | $6.23 |
| Resistance Level | $5.67 | $7.59 |
| Average True Range (ATR) | 0.18 | 0.63 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 20.16 | 75.86 |
PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.